BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15993751)

  • 1. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
    Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
    Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
    J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
    Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells.
    Ackerman WE; Zhang XL; Rovin BH; Kniss DA
    Biol Reprod; 2005 Sep; 73(3):527-35. PubMed ID: 15843495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; IƱiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium.
    Chen NG; Han X
    Biochem Biophys Res Commun; 2001 Apr; 282(3):717-22. PubMed ID: 11401521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.
    Sabichi AL; Subbarayan V; Llansa N; Lippman SM; Menter DG
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1704-9. PubMed ID: 15533896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feedback control of the arachidonate cascade in rheumatoid synoviocytes by 15-deoxy-Delta(12,14)-prostaglandin J2.
    Tsubouchi Y; Kawahito Y; Kohno M; Inoue K; Hla T; Sano H
    Biochem Biophys Res Commun; 2001 May; 283(4):750-5. PubMed ID: 11350047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, ERK, and NF-kappaB, but not p38 MAPK, pathways.
    Chang MS; Chen BC; Yu MT; Sheu JR; Chen TF; Lin CH
    Cell Signal; 2005 Mar; 17(3):299-310. PubMed ID: 15567061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
    Liu J; Lu H; Huang R; Lin D; Wu X; Lin Q; Wu X; Zheng J; Pan X; Peng J; Song Y; Zhang M; Hou M; Chen F
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):400-8. PubMed ID: 15838654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes.
    Lappas M; Permezel M; Ho PW; Moseley JM; Wlodek ME; Rice GE
    Placenta; 2004; 25(8-9):699-704. PubMed ID: 15450387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
    Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
    Laurora S; Pizzimenti S; Briatore F; Fraioli A; Maggio M; Reffo P; Ferretti C; Dianzani MU; Barrera G
    J Pharmacol Exp Ther; 2003 Jun; 305(3):932-42. PubMed ID: 12649303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
    Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S; Rattan R; Singh AK; Singh I
    J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15d-PGJ2: the anti-inflammatory prostaglandin?
    Scher JU; Pillinger MH
    Clin Immunol; 2005 Feb; 114(2):100-9. PubMed ID: 15639643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.